In a recent appearance on the Empowered Patient Podcast, Avalon CEO Bill Kerr, M.D., discusses the emergence of precision medicine and breakthroughs in genomics, the challenges payers and providers face as genetic testing increases in cost and complexity, the impact AI and machine learning will have on the future of lab testing, how Avalon is solving the industry problem of analyzing lab results at scale and much more.
Listen to the full episode:
